Challenges and potential solutions to the evaluation, monitoring, and regulation of surgical innovations

Simple item page
dc.contributor.authorRoberts, Derek J
dc.contributor.authorZygun, David A
dc.contributor.authorBall, Chad G
dc.contributor.authorKirkpatrick, Andrew W
dc.contributor.authorFaris, Peter D
dc.contributor.authorJames, Matthew T
dc.contributor.authorMrklas, Kelly J
dc.contributor.authorHemmelgarn, Brenda D
dc.contributor.authorManns, Braden
dc.contributor.authorStelfox, Henry T
dc.date.accessioned2019-09-01T00:02:25Z
dc.date.available2019-09-01T00:02:25Z
dc.date.issued2019-08-27
dc.date.updated2019-09-01T00:02:25Z
dc.description.abstractAbstract Background As it may be argued that many surgical interventions provide obvious patient benefits, formal, staged assessment of the efficacy and safety of surgical procedures has historically been and remains uncommon. The majority of innovative surgical procedures have therefore often been developed based on anatomical and pathophysiological principles in an attempt to better manage clinical problems. Main Body In this manuscript, we sought to review and contrast the models for pharmaceutical and surgical innovation in North America, including their stages of development and methods of evaluation, monitoring, and regulation. We also aimed to review the present structure of academic surgery, the role of methodological experts and funding in conducting surgical research, and the current system of regulation of innovative surgical procedures. Finally, we highlight the influence that evidence and surgical history, education, training, and culture have on elective and emergency surgical decision-making. The above discussion is used to support the argument that the model used for assessment of innovative pharmaceuticals cannot be applied to that for evaluating surgical innovations. It is also used to support our position that although the evaluation and monitoring of innovative surgical procedures requires a rigorous, fit-for-purpose, and formal system of assessment to protect patient safety and prevent unexpected adverse health outcomes, it will only succeed if it is supported and championed by surgical practice leaders and respects surgical history, education, training, and culture. Conclusion We conclude the above debate by providing a recommended approach to the evaluation, monitoring, and regulation of surgical innovations, which we hope may be used as a guide for all stakeholders involved in interpreting and/or conducting future surgical research.
dc.identifier.citationBMC Surgery. 2019 Aug 27;19(1):119
dc.identifier.doihttps://doi.org/10.1186/s12893-019-0586-5
dc.identifier.urihttp://hdl.handle.net/1880/110836
dc.identifier.urihttps://doi.org/10.11575/PRISM/44836
dc.language.rfc3066en
dc.rights.holderThe Author(s).
dc.titleChallenges and potential solutions to the evaluation, monitoring, and regulation of surgical innovations
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
12893_2019_Article_586.pdf
Size:
427.57 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications